EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -5.365
March 31, 2026 -5.885
December 31, 2025 -5.909
September 30, 2025 -7.882
June 30, 2025 -11.51
March 31, 2025 -0.2213
December 31, 2024 -12.43
September 30, 2024 -0.3512
June 30, 2024 -0.3085
March 31, 2024 -0.3109
December 31, 2023 -0.4242
September 30, 2023 -0.4453
June 30, 2023 -0.5764
March 31, 2023 -0.5691
December 31, 2022 -0.6524
September 30, 2022 -0.543
June 30, 2022 -0.6289
March 31, 2022 -0.4747
December 31, 2021 -0.9491
Date Value
September 30, 2021 -0.2603
June 30, 2021 -0.2794
March 31, 2021 -0.483
December 31, 2020 -2.845
September 30, 2020 -1.382
June 30, 2020 -1.895
March 31, 2020 -1.573
December 31, 2019 -3.194
September 30, 2019 -2.532
June 30, 2019 -3.279
March 31, 2019 -3.207
December 31, 2018 -3.800
September 30, 2018 -3.132
June 30, 2018 -26.50
March 31, 2018 -10.59
December 31, 2017 -7.066
September 30, 2017 -5.152
December 31, 2016 -124.64

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5293
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432

EPS Diluted (Quarterly) Related Metrics